---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-016151"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2022-01-24T23:59:59+00:00"
generated_at: "2026-06-27T16:10:20.335231+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Fluidigm secures $250M in loans and convertible preferred equity; CEO to resign

## Summary
- $25M term loans from Casdin and Viking at 10-16% interest, convertible into Series B preferred, subordinated to SVB loan.
- $225M private placement of Series B-1/B-2 convertible preferred stock (112,500 shares each at $1,000/share) to Casdin and Viking, subject to stockholder approval.
- CEO Stephen Christopher Linthwaite to resign at closing or by May 15, 2022; will receive $1.19M severance plus COBRA and outplacement.
- Proceeds for working capital, general corporate purposes, and potential M&A.
- Each investor gets a board seat with consent rights on major decisions including CEO hiring and M&A over $50M.

## SEC filing metadata
- accession: 0001193125-22-016151
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2022-01-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 3.03, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/0001193125-22-016151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-016151
- JSON: https://secwatch.observer/filing/0001193125-22-016151.json
- Plain text: https://secwatch.observer/filing/0001193125-22-016151.txt

## Key facts
- Executive change
  Stephen Christopher Linthwaite resigned as President and Chief Executive Officer at STANDARD BIOTOOLS INC..
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: Stephen Christopher Linthwaite, the Company’s President and Chief Executive Officer and a member of the Board, will resign on the terms described below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/0001193125-22-016151-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.